CDKN2A and pancreatic ductal adenocarcinoma: Also, mutant p16 can induce oxidation of NADH and maintain glycolysis by generating NAD + , a substrate for GAPDH-mediated glycolytic reaction, thereby promoting pancreatic ductal adenocarcinoma development [59].